Integrated tumor-informed and tumor-agnostic ctDNA molecular residual disease (MRD) assessment with imaging in early breast cancer.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7162548314
